Side-by-side comparison of AI visibility scores, market position, and capabilities
Sales readiness and training platform with scalable content creation, readiness scorecards, and certifications. Now part of the Showpad-Bigtincan revenue enablement entity under Vector Capital.
Brainshark is a sales readiness and training platform originally founded in 1999 and headquartered in Waltham, Massachusetts. The company was acquired by Bigtincan in 2021 and became part of the combined Showpad-Bigtincan revenue enablement platform following the October 2025 merger under Vector Capital. Brainshark is recognized for its scalable content creation tools, sales readiness scorecards, and structured certification workflows.\n\nBrainshark's core capabilities include video-based training content authoring (narrated slide decks and microlearning modules), formal curriculum design, readiness assessments and knowledge checks, coaching submissions where reps record practice pitches for manager review, and readiness scorecards that give sales leaders a real-time view of team certification status. The platform is particularly well-suited for large enterprise rollouts, compliance training, and onboarding programs where organizations need to certify thousands of reps on product knowledge, messaging, and process adherence.\n\nWithin the combined Showpad entity, Brainshark contributes the readiness and training layer, complementing Showpad's content management and Bigtincan's digital sales room capabilities. The combined platform creates an end-to-end revenue enablement stack from content management through training certification and buyer engagement. Brainshark's integrations include Salesforce, Microsoft SharePoint, and major SCORM-compliant LMS environments.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.